A second individual has achieved sustained remission from HIV-1 after ceasing antiretroviral treatment, according to researchers from University College London. Following a hematopoietic stem cell transplant and chemotherapy the patient has had undetectable viral loads for 18 months.
New research has developed a nanoparticle formulation that can knock down a key chlamydia binding protein and simultaneously induce autophagy – showing promise against this infection.
Take a look behind the scenes of a recent Future Virology paper as we ask author Darrell Tan about the potential of pre-exposure prophylaxis (PrEP) for HIV prevention, PrEP failure and what research is needed in the field.
State media has reported that the number of people living with HIV/AIDS has increased by 14% year-on-year.
The European Gonococcal Antimicrobial Surveillance Programme has revealed high levels of azithromycin resistance in Europe, however, these have remained relatively stable.
Primarily transferred via direct contact with the blood or bodily fluids of infected people, the Ebola virus receives a significant boost to its infective properties from amyloid fibrils in human semen, according to a new study.
Data from Public Health England has reported a 20% rise in cases of syphilis and a 22% rise in gonorrhoea, a concern with the emergence of multi-drug resistance.
The US FDA and the European Medicines Agency are investigating reports of neural tube defects in babies born to women on GlaxoSmithKline’s antiretroviral drug dolutegravir.
Listen to our podcast rounding up the top news stories of the week, including the measles vaccine and the sexual transmission of Zika.
A new study has revealed that a promising antioxidant drug could prevent sexual transmission of the Zika virus, offering a potential role for the drug in preventing spread among humans.
